Nirvana Life Sciences Inc. (CSE:NIRV)
Canada
· Delayed Price · Currency is CAD 0.0350
-0.0150 (-30.00%)
Feb 12, 2025, 9:04 AM EST
-22.22% (1Y)
| Market Cap | 1.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -459.52K |
| Shares Out | 48.23M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 30,700 |
| Average Volume | 1,535 |
| Open | 0.0350 |
| Previous Close | 0.0500 |
| Day's Range | 0.0350 - 0.0350 |
| 52-Week Range | 0.0100 - 0.0800 |
| Beta | 0.76 |
| RSI | 12.34 |
| Earnings Date | Apr 3, 2025 |